Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART outcomes with two ovulation induction protocols in women with hypogonadotropic hypogonadism
IRCT201312251141N16Phase 4Completed
- Sponsor
- Royan Institute
- Start
- Nov 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of gonadorelin in female infertility and hypogonadotropic hypogonadism (HH) (2 arms), sponsored by Royan Institute. Started Nov 2012; status: completed.
02
Drugs
gonadorelin
03
Conditions
female infertilityhypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on IRCT201312251141N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312251141N16.